Bismuth Subgallate and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Bismuth Subgallate and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bismuth subgallate
Brand name: Devrom
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bismuth Subgallate-Insulin degludec
- Bismuth Subgallate-Insulin Degludec (U-100) Prefilled Pens
- Bismuth Subgallate-Insulin Degludec (U-100) Vials
- Bismuth Subgallate-Insulin Degludec (U-200) Prefilled Pens
- Bismuth Subgallate-Insulin degludec and liraglutide
- Bismuth Subgallate-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Bismuth subsalicylate
- Insulin aspart, recombinant Subcutaneous-Bismuth Subsalicylate Chewable Tablets
- Insulin aspart, recombinant Subcutaneous-Bismuth Subsalicylate Suspension
- Insulin aspart, recombinant Subcutaneous-Bismuth Subsalicylate Tablets
- Insulin aspart, recombinant Subcutaneous-Bismuth subsalicylate, metronidazole, and tetracycline
- Insulin aspart, recombinant Subcutaneous-Bisoprolol